Table I.
Baseline characteristics of TESAOD participants at the time of blood collection.
| N | 1088 |
|
| |
| Females: N (%) | 639/1088 (58.7%) |
|
| |
| Age: mean; range in years | 46 (21 – 70) |
|
| |
| Body Mass Index: N (%) | |
| Under-weight (< 18.5 Kg/m2) | 21 (2.0%) |
| Normal-weight (≥18.5, < 25 Kg/m2) | 612 (58.2%) |
| Over-weight (≥ 25, < 30 Kg/m2) | 344 (32.7%) |
| Obese (≥ 30 Kg/m2) | 75 (7.1%) |
|
| |
| Smoking status: N (%) | |
| Never | 431 (39.7%) |
| Former | 268 (24.7%) |
| Current | 388 (35.7%) |
|
| |
| Smoke intensity in pack-years: N (%) | |
| 0 pack-years | 431 (39.7%) |
| >0; ≤10 pack-years | 210 (19.3%) |
| >10; ≤20 pack-years | 141 (13.0%) |
| >20; ≤40 pack-years | 170 (15.7%) |
| >40 packyears | 134 (12.3%) |
|
| |
| Physician-confirmed asthma: N (%) | |
| Never | 965 (88.8%) |
| Inactive | 52 (4.8%) |
| Active | 70 (6.4%) |
|
| |
| Atopy*: N (%) | 412/1075 (38.3%) |
|
| |
| Spirometric patterns: N (%) | |
| Normal | 846 (77.8%) |
| Restrictive | 114 (10.5%) |
| Obstructive | 128 (11.8%) |
|
| |
| FEV1 % predicted: mean; SD | 94.8% (18) |
|
| |
| FVC % predicted: mean; SD | 97.5% (17) |
|
| |
| FEV1/FVC ratio %: mean; SD | 80.2% (10) |
|
| |
| YKL40: mean; median; IQR in ng/ml | 46.5; 34.0; 23.5 – 54.3 |
*
defined as having a skin prick test wheal ≥ 2 mm larger than control for ≥ one of 5 tested allergens